US Broker Ratings

ICU Medical, Inc. (ICUI) Stock Analysis: Potential 21.91% Upside with Strong Buy Ratings

Investors seeking opportunities in the healthcare sector may find ICU Medical, Inc. (NASDAQ: ICUI) a compelling choice, given its robust potential upside and solid analyst ratings. The company, specializing in..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 30% Potential Upside Amid Robust Revenue Growth

U.S. Physical Therapy, Inc. (NYSE: USPH) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Houston, Texas, this company is distinguished by..

Phreesia, Inc. (PHR) Stock Analysis: A Potential 81% Upside with Strong Buy Consensus

Phreesia, Inc. (PHR) is making waves in the healthcare sector, specifically within the health information services industry. With a market capitalization nearing the billion-dollar mark at $992.93 million, Phreesia is..

Galapagos NV (GLPG) Stock Analysis: Can This Belgian Biotech Power Through a Potential -14.32% Downside?

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is navigating turbulent waters in the healthcare sector. With a market capitalization of $2.14 billion, the company is focused on developing innovative..

Mesoblast Limited (MESO) Stock Analysis: Exploring an 80% Upside Potential in Regenerative Medicine

Mesoblast Limited (NASDAQ: MESO) stands as a compelling player in the biotechnology sector, particularly in the niche of regenerative medicine. Headquartered in Melbourne, Australia, Mesoblast is carving a unique path..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth Amidst Healthcare Challenges

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the healthcare sector, specializes in neonatal and maternal-fetal care, providing critical services to vulnerable populations across the United States. With..

Disc Medicine, Inc. (IRON) Stock Analysis: Analyst Buy Ratings and 52.96% Potential Upside Capture Investor Attention

Disc Medicine, Inc. (NASDAQ: IRON) has emerged as a fascinating prospect within the healthcare sector, particularly in the burgeoning biotechnology industry. With a market capitalization of $3 billion, this clinical-stage..

IDEAYA Biosciences, Inc. (IDYA)

⚠️ No article content returned.

..

Azenta, Inc. (AZTA) Stock Analysis: Capturing a Potential 15.79% Upside in the Healthcare Sector

Investors with an eye on the healthcare sector might find Azenta, Inc. (NASDAQ: AZTA) an intriguing prospect, especially given its positioning in the burgeoning field of life sciences. With its..

Investor Outlook: AdaptHealth Corp. (AHCO) Poised for 28.77% Upside with Strong Buy Ratings

AdaptHealth Corp. (NASDAQ: AHCO) is drawing significant attention in the healthcare sector, particularly among investors eyeing the medical devices industry. Headquartered in Plymouth Meeting, Pennsylvania, and founded in 2012, AdaptHealth..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring an 84% Potential Upside in Neurodegenerative Treatment Innovations

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out as a promising player in the biotechnology sector, focusing on groundbreaking treatments for neurodegenerative and lysosomal storage diseases. With a market capitalization of..

Xenon Pharmaceuticals (XENE) Stock Analysis: A 20% Upside Potential Awaits Investors in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology company, is capturing the attention of the investment community with its promising pipeline in the neuroscience domain. The company is currently valued..

Evotec SE (EVO) Stock Analysis: Navigating 87.58% Potential Upside Amidst Challenges

Evotec SE (EVO), a prominent player in the healthcare sector specializing in drug discovery and development, is capturing investor attention with its significant potential upside of 87.58%. This German-based company,..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a 6.16% Potential Upside in CNS Therapeutics

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands at the forefront of biotechnology, with a strategic focus on developing and commercializing medications for central nervous system (CNS) disorders and rare diseases. Headquartered..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Promising Biotech with Significant Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is making waves in the biotechnology sector with its innovative approach to peptide therapeutics. With a focus on hematology, blood disorders, and inflammatory diseases, this..

Supernus Pharmaceuticals, Inc. (SUPN): Analyst Consensus and Growth Prospects Unveiled

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, specifically within the specialized realm of drug manufacturing for central nervous system (CNS) diseases. With a market capitalization..

CONMED Corporation (CNMD) Investor Outlook: Assessing a 20.88% Potential Upside in the Medical Devices Sector

CONMED Corporation (NYSE: CNMD), a prominent player in the healthcare sector, particularly in the medical devices industry, is capturing investor attention with a potential upside of 20.88% based on the..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Potential Upside with a 26.41% Gain Insight

Teladoc Health, Inc. (NYSE: TDOC), a prominent player in the virtual healthcare industry, is capturing investor attention with a potential upside of 26.41%. As a leading provider of telehealth services,..

National HealthCare Corporation (NHC): Evaluating Growth Potential Amidst Record Highs

With a robust market presence and a diverse range of healthcare services, National HealthCare Corporation (NYSE: NHC) stands as a noteworthy entity in the medical care facilities industry. Boasting a..

Schrodinger, Inc. (SDGR) Stock Analysis: Unpacking a 40% Potential Upside in Health Information Services

For investors seeking exposure in the healthcare sector, Schrodinger, Inc. (NASDAQ: SDGR) offers an intriguing opportunity. With a market capitalization of $1.43 billion, this New York-based company is a leader..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds